Headline News about DICE Therapeutics, Inc. - Common Stock![]()
Recap: DICE Therapeutics Q1 Earnings
May 11, 2023
Via Benzinga
![]() ![]() Via Benzinga
![]()
Where DICE Therapeutics Stands With Analysts
November 15, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|